Table 2.

Cardiac Function of Women With Breast Cancer, Treated With DOX-Based Chemotherapy

	No. of Patients	Average LVEF (%) at Baseline (Mean ± SD)	Average LVEF (%) at Completion of Chemotherapy (Mean ± SD)
Patients with abnormal LVEF (%)	10	69.875 ± 5.436	57.875 ± 3.833
18–47 years	2	68.5 ± 2.121	57.5 ± 0.707
48–55 years	2	64.0 ± 0	54.0 ± 0
>56 years	4	73.5 ± 5.066	60.0 ± 4.242
Patients with normal LVEF (%)	20	61.583 ± 5.523	61.833 ± 6.919
18–47 years	9	60.888 ± 6.050	62.222 ± 9.162
48–55 years	9	60.888 ± 5.065	59.777 ± 5.118
>56 years	7	63.142 ± 5.080	57.714 ± 6.499

MUGA scan was performed before the start of DOX chemotherapy and at its completion. LVEF, left ventricle ejection fraction.